CBD: a biomarker database for colorectal cancer
暂无分享,去创建一个
Hong Zhang | Bairong Shen | Yang Cao | Xingyun Liu | Xueli Zhang | Benchen Ye | Qiliang Peng | Xiao-Feng Sun | Bairong Shen | Hong Zhang | Xiao-Feng Sun | Xueli Zhang | Q. Peng | Xingyun Liu | Yang Cao | Benchen Ye | Bairong Shen
[1] Bharati Bapat,et al. Epigenetic biomarkers in colorectal cancer diagnostics , 2012, Expert review of molecular diagnostics.
[2] R. Henrik Nilsson,et al. Finding needles in haystacks: linking scientific names, reference specimens and molecular data for Fungi , 2014, Database J. Biol. Databases Curation.
[3] Peter B. Schiff,et al. Surveillance Epidemiology and End Results (SEER) analysis confirms overall survival benefit with concurrent chemoradiotherapy for cervical cancer , 2013 .
[4] Hong Zhang,et al. Tafazzin Protein Expression Is Associated with Tumorigenesis and Radiation Response in Rectal Cancer: A Study of Swedish Clinical Trial on Preoperative Radiotherapy , 2014, PloS one.
[5] Danny Chuon,et al. Gastric Cancer (Biomarkers) Knowledgebase (GCBKB): A Curated and Fully Integrated Knowledgebase of Putative Biomarkers Related to Gastric Cancer , 2006, Biomarker insights.
[6] Ahmedin Jemal,et al. Global Cancer Incidence and Mortality Rates and Trends—An Update , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[7] Ana Kozomara,et al. miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..
[8] A. Jemal,et al. Colorectal cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[9] J. Hardcastle,et al. Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.
[10] L. Hood,et al. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. , 2012, New biotechnology.
[11] Charles Auffray,et al. P4 medicine needs P4 education. , 2014, Current pharmaceutical design.
[12] Bairong Shen,et al. Knowledge-Guided Bioinformatics Model for Identifying Autism Spectrum Disorder Diagnostic MicroRNA Biomarkers , 2016, Scientific Reports.
[13] C. Sawyers. The cancer biomarker problem , 2008, Nature.
[14] Bairong Shen,et al. Integrative analysis reveals disease-associated genes and biomarkers for prostate cancer progression , 2014, BMC Medical Genomics.
[15] Hong Zhang,et al. WRAP53 is an independent prognostic factor in rectal cancer- a study of Swedish clinical trial of preoperative radiotherapy in rectal cancer patients , 2012, BMC Cancer.
[16] David L. Wheeler,et al. GenBank , 2015, Nucleic Acids Res..
[17] Paula Ribeiro,et al. miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis , 2016, Nucleic Acids Res..
[18] L. Hood,et al. Predictive, personalized, preventive, participatory (P4) cancer medicine , 2011, Nature Reviews Clinical Oncology.
[19] M. Phipps,et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.
[20] Ming Yi,et al. bioDBnet: the biological database network , 2009, Bioinform..
[21] Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation , 2008, Annals of Internal Medicine.
[22] Jiajia Chen,et al. Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network , 2016, Oncotarget.
[23] In Seok Yang,et al. IDBD: Infectious Disease Biomarker Database , 2007, Nucleic Acids Res..
[24] J. Somberg,et al. Biomarkers and surrogate endpoints. , 1999, American journal of therapeutics.
[25] Claudia M Denkinger,et al. A tuberculosis biomarker database: the key to novel TB diagnostics. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[26] Damian Szklarczyk,et al. The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible , 2016, Nucleic Acids Res..
[27] D. DeMets,et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.
[28] J. Hill,et al. Review of biomarkers in colorectal cancer , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[29] J. Aronson. Biomarkers and surrogate endpoints. , 2005, British journal of clinical pharmacology.
[30] P. Mendola,et al. Development of a biomarkers database for the National Children's Study. , 2005, Toxicology and applied pharmacology.
[31] Rebecca L. Siegel Mph,et al. Colorectal cancer statistics, 2014 , 2014 .
[32] Mukesh Verma,et al. Epigenetic Biomarkers in Colorectal Cancer , 2016, Molecular Diagnosis & Therapy.
[33] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[34] Wen-Lian Hsu,et al. LiverCancerMarkerRIF: a liver cancer biomarker interactive curation system combining text mining and expert annotations , 2014, Database J. Biol. Databases Curation.
[35] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.